Certara Products - Simcyp Archives | Page 3 of 24

On-Demand Webinar

Certara’s Simcyp Educational Webinar Series: Learn from A to Z of PBBM Part 2: What is the Drug Absorption Model?

Part 3 in November: Understanding the Supersaturated Dissolution in the Digestive Tract with Modeling &…

CertaraMay 12, 2025

On-Demand Webinar

Clinical and Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib Drug–Drug Interactions

Director, Clinical Pharmacology, ORIC Pharmaceuticals SVP, Head of Simcyp PBPK Modeling Services, Certara Director, PBPK…

CertaraApril 21, 2025

Case Study

Enabling Personalized Therapy with PBPK Modeling for Pediatric Epilepsy

GRIN Therapeutics, Inc., an affiliate of Neurvati Neurosciences, focuses on the research and development of…

CertaraApril 16, 2025

Press Coverage

FDA to phase out animal testing with AI and lab-based models

FDA aims to replace animal testing in drug development with AI and lab-based models, enhancing…

CertaraApril 11, 2025

On-Demand Webinar

Model-informed Formulation Development: Bridging Experimental Data and Mechanistic Modeling

Discover how predictive modeling and model-informed formulation development (MIFD) are accelerating drug development. Learn from…

CertaraApril 11, 2025

Blog

Write Quicker PBPK Reports with the Simcyp Report Assistant

April 11, 2025 Writing a report for PBPK models can be an onerous process, especially…

CertaraApril 11, 2025

Press Release

Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

RADNOR, PA — April 1st, 2025 – Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraApril 1, 2025

On-Demand Webinar

MIDD’s Growing Role in Global Health: A Case Study of Primaquine Exposures in Lactating Women and Breastfed Infants

Explore how model-informed drug development (MIDD) enhanced clinical lactation studies and supported global health policy…

CertaraMarch 28, 2025

On-Demand Webinar

PBBM Educational Webinar Series (Part 1): The Basics of Drug Absorption in Drug Development – Why is Drug Absorption Essential? [Japanese Webinar]

Part 2 on July 17th : What is the Drug Absorption Model? Part 3 in…

CertaraFebruary 27, 2025

On-Demand Webinar

Simcyp Version 24: Advancing PBPK capabilities and translating new science and technology into regulatory-accepted predictive modeling

With the release of Version 24, the Simcyp Simulator introduces cutting-edge enhancements that further elevate…

CertaraFebruary 7, 2025

Certara Products – Simcyp

Certara’s Simcyp Educational Webinar Series: Learn from A to Z of PBBM Part 2: What is the Drug Absorption Model?

Clinical and Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib Drug–Drug Interactions

Enabling Personalized Therapy with PBPK Modeling for Pediatric Epilepsy

FDA to phase out animal testing with AI and lab-based models

Model-informed Formulation Development: Bridging Experimental Data and Mechanistic Modeling

Write Quicker PBPK Reports with the Simcyp Report Assistant

Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

MIDD’s Growing Role in Global Health: A Case Study of Primaquine Exposures in Lactating Women and Breastfed Infants

PBBM Educational Webinar Series (Part 1): The Basics of Drug Absorption in Drug Development – Why is Drug Absorption Essential? [Japanese Webinar]

Simcyp Version 24: Advancing PBPK capabilities and translating new science and technology into regulatory-accepted predictive modeling

Newsletter sign up

Quick links

Solutions

Contact